CXCL8 as a Potential Therapeutic Target for HIV-Associated Neurocognitive Disorders

E-ISSN： 1873-5592|17|1|111-121

ISSN： 1389-4501

Source： Current Drug Targets, Vol.17, Iss.1, 2016-01, pp. : 111-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cross-Talk Between NO Synthase Isoforms in Neuro-Inflammation: Possible Implications in HIV-Associated Neurocognitive Disorders

Current Medicinal Chemistry, Vol. 23, Iss. 24, 2016-07 ,pp. : 2706-2714

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Roles of Microglial Cell Progranulin in HIV-Associated CNS Pathologies and Neurocognitive Impairment

By Suh Hyeon-Sook Gelman Benjamin Lee Sunhee

Journal of Neuroimmune Pharmacology, Vol. 9, Iss. 2, 2014-03 ,pp. : 117-132

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic options for HIV-associated lymphomas

By Spina Michele Gloghini Annunziata Tirelli Umberto Carbone Antonino

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2471-2481

Informa Healthcare

Access to resources Recommend Favorite

Role of Neurotrophic Factor Alterations in the Neurodegenerative Process in HIV Associated Neurocognitive Disorders

By Fields Jerel Dumaop Wilmar Langford T. Rockenstein Edward Masliah E.

Journal of Neuroimmune Pharmacology, Vol. 9, Iss. 2, 2014-03 ,pp. : 102-116

Springer Publishing Company

Access to resources Recommend Favorite

Gabexate ± octreotide for HIV-associated pancreatic disorders

Inpharma, Vol. 1, Iss. 1362, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite